SE381874B - Sett att framstella farmakologiskt aktiva anilinobensotiazoler och farmakologiskt acceptabla syraadditionssalter derav - Google Patents

Sett att framstella farmakologiskt aktiva anilinobensotiazoler och farmakologiskt acceptabla syraadditionssalter derav

Info

Publication number
SE381874B
SE381874B SE7304423A SE7304423A SE381874B SE 381874 B SE381874 B SE 381874B SE 7304423 A SE7304423 A SE 7304423A SE 7304423 A SE7304423 A SE 7304423A SE 381874 B SE381874 B SE 381874B
Authority
SE
Sweden
Prior art keywords
anilinobensotiazoles
methods
acceptable acid
preparing
additional salts
Prior art date
Application number
SE7304423A
Other languages
English (en)
Swedish (sv)
Inventor
C J Sharpe
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of SE381874B publication Critical patent/SE381874B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7304423A 1972-03-30 1973-03-29 Sett att framstella farmakologiskt aktiva anilinobensotiazoler och farmakologiskt acceptabla syraadditionssalter derav SE381874B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1501872A GB1417402A (en) 1972-03-30 1972-03-30 Pharmacologically active anilinobenzothiazoles

Publications (1)

Publication Number Publication Date
SE381874B true SE381874B (sv) 1975-12-22

Family

ID=10051624

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7304423A SE381874B (sv) 1972-03-30 1973-03-29 Sett att framstella farmakologiskt aktiva anilinobensotiazoler och farmakologiskt acceptabla syraadditionssalter derav

Country Status (19)

Country Link
US (1) US3897443A (US06168655-20010102-C00055.png)
JP (1) JPS4924959A (US06168655-20010102-C00055.png)
AR (4) AR210050A1 (US06168655-20010102-C00055.png)
AT (1) AT323738B (US06168655-20010102-C00055.png)
BE (1) BE797623A (US06168655-20010102-C00055.png)
CA (1) CA1019747A (US06168655-20010102-C00055.png)
CH (1) CH576976A5 (US06168655-20010102-C00055.png)
CS (4) CS184341B2 (US06168655-20010102-C00055.png)
DE (1) DE2315791A1 (US06168655-20010102-C00055.png)
ES (4) ES413153A1 (US06168655-20010102-C00055.png)
FR (1) FR2182910B1 (US06168655-20010102-C00055.png)
GB (1) GB1417402A (US06168655-20010102-C00055.png)
HU (1) HU164716B (US06168655-20010102-C00055.png)
IE (1) IE37439B1 (US06168655-20010102-C00055.png)
LU (1) LU67336A1 (US06168655-20010102-C00055.png)
NL (1) NL7304353A (US06168655-20010102-C00055.png)
SE (1) SE381874B (US06168655-20010102-C00055.png)
SU (3) SU556729A3 (US06168655-20010102-C00055.png)
ZA (1) ZA731867B (US06168655-20010102-C00055.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU534093B2 (en) * 1979-03-19 1984-01-05 Ici Australia Limited Thiazoles,benzthiazoles, benzoxazoles and benzimidazoles
SE0104140D0 (sv) * 2001-12-07 2001-12-07 Astrazeneca Ab Novel Compounds
ES2308731T3 (es) 2005-02-16 2008-12-01 Astrazeneca Ab Compuestos quimicos.
WO2006123113A2 (en) * 2005-05-16 2006-11-23 Astrazeneca Ab Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
WO2008129255A1 (en) * 2007-04-18 2008-10-30 Astrazeneca Ab 5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
US20100137398A1 (en) * 2007-05-04 2010-06-03 Novartis Ag Use of hdac inhibitors for the treatment of gastrointestinal cancers
UA99459C2 (en) * 2007-05-04 2012-08-27 Астразенека Аб 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
AR072085A1 (es) * 2008-06-11 2010-08-04 Astrazeneca Ab Compuestos triciclicos, metodos para su preparacion, composicion farma-ceutica que los comprende y su uso en el tratamiento de enfermedades me-diadas por la actividad de las proteinas quinasas
BRPI0919488A2 (pt) * 2008-09-30 2015-12-01 Astrazeneca Ab composto, uso de um composto, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2040928A (en) * 1936-05-19
US2676970A (en) * 1952-01-30 1954-04-27 Hoffmann La Roche Benzothiazole derivatives
GB1153648A (en) * 1967-03-22 1969-05-29 Twyford Lab Ltd Substituted 2-Anilino Benzothiazole Basic Ethers

Also Published As

Publication number Publication date
AR210050A1 (es) 1977-06-30
AU5357273A (en) 1974-09-26
SU556729A3 (ru) 1977-04-30
HU164716B (US06168655-20010102-C00055.png) 1974-04-11
FR2182910B1 (US06168655-20010102-C00055.png) 1976-09-03
BE797623A (fr) 1973-07-16
SU555853A3 (ru) 1977-04-25
CA1019747A (en) 1977-10-25
NL7304353A (US06168655-20010102-C00055.png) 1973-10-02
ZA731867B (en) 1973-12-19
JPS4924959A (US06168655-20010102-C00055.png) 1974-03-05
ES441616A1 (es) 1977-04-01
DE2315791A1 (de) 1973-10-04
CH576976A5 (US06168655-20010102-C00055.png) 1976-06-30
IE37439B1 (en) 1977-07-20
CS184324B2 (en) 1978-08-31
ES432027A1 (es) 1976-11-01
US3897443A (en) 1975-07-29
CS184342B2 (en) 1978-08-31
ES413153A1 (es) 1976-01-16
SU584775A3 (ru) 1977-12-15
AR197545A1 (es) 1974-04-15
AR204986A1 (es) 1976-03-31
CS184341B2 (en) 1978-08-31
CS184343B2 (en) 1978-08-31
FR2182910A1 (US06168655-20010102-C00055.png) 1973-12-14
ES432026A1 (es) 1976-11-01
AR210756A1 (es) 1977-09-15
LU67336A1 (US06168655-20010102-C00055.png) 1973-06-15
AT323738B (de) 1975-07-25
IE37439L (en) 1973-09-30
GB1417402A (en) 1975-12-10

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
FI56478B (fi) Foerfaringssaett foer framstaellning av en fettemulsion med laogt kalorivaerde och hoeg proteinhalt
SE402916B (sv) Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
SE409460B (sv) Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika
SE7611316L (sv) Prostansyraderivat och sett for framstellning derav
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE381874B (sv) Sett att framstella farmakologiskt aktiva anilinobensotiazoler och farmakologiskt acceptabla syraadditionssalter derav
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO138061C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive substituerte difenylpropionsyrederivater
SE388420B (sv) Sett att framstella cyklopropylmetylaminderivat
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE401674B (sv) Forfarande for framstellning av farmakologiskt aktiva bensocykloheptaisokinolinderivat samt syraadditionssalter derav
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
BE795474A (fr) Sels alcalins d'acides polyester-carboxyliques, et leur preparation
SE398874B (sv) Sett att framstella lysinkalciumklorid och farmaceutiskt godtagbara syraadditionsssalter derav
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE7308998L (sv) Sett att framstella nya aminoimidazoisokinolinderivat och salter derav
SE400767B (sv) Forfarande for framstellning av arylpiperazin-derivat av adenin
IT994096B (it) Procedimento per la produzione di sali di aurammina e soluzioni di sali di aurammina
SE398644B (sv) Sett att framstella farmaceutiskt aktiva 2,10-diklor-12-metyl-(2h-dibenso(d g))1,3)-dioxocinderivat
BE802345A (fr) Nouveau derive d'acide 1,4-dihydro-1-substitute-4-oxo-3-quinoleine-carboxylique
NO144069C (no) Difluorbutyrofenonderivater som er anvendelige for fremstilling av terapeutisk aktive butyrofenonderivater